ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,617.20
0.38%
US Tech 100
19,004.00
0.40%
Dow Jones
41,346.54
0.61%
Brent Oil
71.575
-0.55%
Bitcoin
59,801.06
2.86%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. G1 Therapeutics Inc (GTHX)

  7. G1 Therapeutics Inc (GTHX) News

GTHX

G1 Therapeutics (GTHX)

G1 Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GTHX
DateTimeSourceHeadlineSymbolCompany
09/10/202411:41AMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:GTHXG1 Therapeutics Inc
09/05/20248:02AMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:GTHXG1 Therapeutics Inc
09/05/20247:32AMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:GTHXG1 Therapeutics Inc
09/05/20246:30AMGlobeNewswire Inc.Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting PeriodNASDAQ:GTHXG1 Therapeutics Inc
08/20/20243:40PMEdgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:GTHXG1 Therapeutics Inc
08/20/20243:24PMEdgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:GTHXG1 Therapeutics Inc
08/19/20247:02PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:GTHXG1 Therapeutics Inc
08/14/20244:33PMEdgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:GTHXG1 Therapeutics Inc
08/09/202410:17AMPR Newswire (US)Kuehn Law Encourages BAYA, RCFA, OBDC, and GTHX Investors to Contact Law FirmNASDAQ:GTHXG1 Therapeutics Inc
08/08/20244:14PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTHXG1 Therapeutics Inc
08/08/20244:01PMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:GTHXG1 Therapeutics Inc
08/08/20246:54AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTHXG1 Therapeutics Inc
08/08/20246:30AMGlobeNewswire Inc.G1 Therapeutics Provides Second Quarter 2024 Financial Results and Operational HighlightsNASDAQ:GTHXG1 Therapeutics Inc
08/07/20245:30PMEdgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:GTHXG1 Therapeutics Inc
08/07/20245:10PMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:GTHXG1 Therapeutics Inc
08/07/20245:03PMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:GTHXG1 Therapeutics Inc
08/07/20249:21AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTHXG1 Therapeutics Inc
08/07/20246:29AMGlobeNewswire Inc.Pharmacosmos Group to Acquire G1 TherapeuticsNASDAQ:GTHXG1 Therapeutics Inc
08/01/20246:50PMGlobeNewswire Inc.G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GTHXG1 Therapeutics Inc
07/25/202411:15AMGlobeNewswire Inc.G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024NASDAQ:GTHXG1 Therapeutics Inc
07/08/20245:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
07/08/20245:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
07/08/20245:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
07/08/20245:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
07/08/20245:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
07/01/20248:00AMGlobeNewswire Inc.G1 Therapeutics Added to the Russell 2000® and 3000® IndexesNASDAQ:GTHXG1 Therapeutics Inc
06/24/20246:30AMGlobeNewswire Inc.G1 Therapeutics Provides Update on Phase 3 PRESERVE 2 Trial in Patients Receiving Trilaciclib Prior to First Line Chemotherapy in Metastatic Triple Negative Breast Cancer (mTNBC)NASDAQ:GTHXG1 Therapeutics Inc
06/14/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
06/14/20244:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
06/14/20244:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GTHX

Your Recent History

LSE
OUT7
Emirate Ab 25 S
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved